Morgan O'Neal
Acute Care · Monroe, LANPI 1306293436
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 248 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 27.1% of the total. Reporting peaked in 2021 at $1,544 and has fallen 71.7% since, to $438 in 2025.
Across 248 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$923
- Johnson & Johnson$395
- Bristol Myers Squibb$376
- Nestle Healthcare Nutrition Inc.$306
- Takeda Pharmaceuticals U.S.A., Inc.$207
- plus $826 from 16 others
What the payments were for
- Food & beverage$4,158100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 108 | $1,125 |
| AbbVie | 49 | $923 |
| Johnson & Johnson | 22 | $395 |
| Bristol Myers Squibb | 20 | $376 |
| Nestle Healthcare Nutrition Inc. | 9 | $306 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $207 |
| Lilly USA, LLC | 2 | $204 |
| Mallinckrodt Hospital Products Inc. | 1 | $138 |
| Aimmune Therapeutics, Inc. | 1 | $124 |
| Redhill Biopharma Inc. | 4 | $54 |
| Ardelyx, Inc. | 3 | $49 |
| Sanofi | 1 | $48 |
| Intercept Pharmaceuticals, Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Pfizer | 2 | $29 |
| Gilead | 2 | $28 |
| QOL Medical, LLC | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Evoke Pharma, Inc. | 1 | $14 |
| Braintree Laboratories, Inc. | 1 | $12 |
| Merck | 1 | $12 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,158 in reported general payments places this provider in the 85th percentile of 248 acute care providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 20 | $4,501 |
| Dexlansoprazole DrDexlansoprazole | 16 | $4,497 |
| Pantoprazole Sodium | 44 | $714 |
| Omeprazole | 33 | $284 |
Paid to pharmacies, not to this prescriber.
Other acute care in Monroe
- Dena NovakMonroe$6K
- Livia ZalewskiMonroe$4K
- Amanda HooperMonroe$2K
- Landry BagwellMonroe$2K
- Deanna McKeeMonroe$2K
- Precious HodgesLafayette$70K
- Brinton FegleyShreveport$61K
- Charles JarreauNew Orleans$40K
- Jeremy DavisShreveport$35K
- Heather MecomShreveport$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.